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Abstract
The debate between the use of radiofrequency (RF) or cryoenergy for ablation near
the atrioventricular (AV) conducting system or small coronaries has been fueled by
the relative efficacies and risks of the two technologies, particularly in smaller hearts.
The manuscript by Schneider et al adds another chapter to that ongoing debate.
In this issue of the Journal, Schneider et al1 continue to enhance our
knowledge of the effects of catheter ablation on various cardiac
structures both immediately and longitudinally. Adding to an over
20‐year history of excellent and similarly focused research from
Dr. Paulʼs laboratory, the current study examines the late effects of
“freeze‐thaw‐freeze” cryoablation applications on the adjacent
coronary arteries. Prior studies from the same group have evaluated
both acute and late effects of radiofrequency (RF) and cryoablation
on the coronaries. This latest study incorporates the widely utilized
technique of repetitive cryoablation applications at a target site to
maximize efficacy.
Schneider et al2 find in their porcine model that there were no
identifiable coronary effects by angiography or intracardiac ultra-
sound (ICUS), either acutely or at 6 month follow‐up. However,
pathological examination at 6 months did demonstrate very mild
effects on the coronaries in two of 29 lesions, including mild medial
and adventitial thickening, minimal intimal proliferation, and a small
intraluminal thrombus at one site of intimal proliferation. Though
potentially relevant clinically, these findings are far less concerning
than the clearly concerning coronary issues found in this groupʼs and
others past studies using RF energy in both animals and humans.3
The lack of more than minimal effects in the current study add to
the growing list of evidence that cryoablation is a considerably safer
technique than RF ablation. Minimal late effects on the coronaries
(even with a freeze‐thaw‐freeze technique), can be added to lesion
reversibility, catheter adherence during freeze, decreased thrombus
formation, and extremely low risk of inadvertent permanent damage
to the conduction system as benefits of cryoablation vs RF. In fact,
during an audience survey after a May 2019 debate sponsored by the
Pediatric and Congenital Electrophysiology Society (PACES) with 180
electrophysiology health care providers present, not one provider
reported more than a 2‐week period of complete AV block after
cryoablation, supporting the absence in the literature of any patient
requiring permanent pacing for a cryo application delivered to treat
atrioventricular nodal reentry tachycardia (AVNRT) or an accessory
pathway (AP).
Even with a higher safety profile, cryoablation has faced an uphill
battle to be accepted as the preferred ablation modality for ablation
near vital structures like the AV conduction system or small
coronaries. The most prominent barrier has been the early clinical
studies on transcatheter cryoablation, which showed decreased
efficacy and higher recurrence rates vs RF ablation for typical
substrates such as AVNRT or an AP. However, the two techniques
were in different stages of development, and since these initial
studies, the technique of cryoablation application has evolved with
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larger catheter tips, varying application durations and strategies, and
the addition of the freeze‐thaw‐freeze technique to name just a few,
all enhancing the learning curve. Consequently, these early studies
are essentially irrelevant in light of modern practice. In fact, a current
review of the literature shows that with more contemporary
approaches to cryoablation of AVNRT, including the use of a
freeze‐thaw‐freeze cycle, the combined acute and late failure risk
for pediatric patients has gone from around 16% to 4%, similar to RF.
Despite this evolution, proponents of RF over cryoablation and even
guidelines statements, continue to reference these early studies in
their assessment of efficacy, which is often prioritized over safety.
In light of the current study, the freeze‐thaw‐freeze technique is
of particular interest. For pediatric electrophysiologist utilizing
cryoablation, the technique commonly used seems to be a pattern
of (a) cryoapplication for 4 to 6minutes, (b) brief thawing period (15‐
60 seconds) and (c) reapplication of cryoablation at the same site,
ideally identified by a three‐dimensional mapping technique. If the
patient is mechanically ventilated, a held expiration before the end of
the freeze and continued through the thaw period can help assure
the second freeze is in the same location. The use of a triple freeze
technique has also been reported.4 Although Schneider et al1 credit
the application of the freeze‐thaw‐freeze approach to Drago in
2006,5 the authors in that paper seemed to be using a “bonus”
application added to the site of success 30minutes after the initial
cryoablation application, rather than the freeze‐thaw‐freeze cycle
used by Schneider. From a review of the multiple cryoablation papers
published in the surrounding years, no paper before the triple freeze
cycle reported in 20134 specifically focuses on the double freeze
technique, however, between 2005 and 2015, the technique became
commonly utilized. Nonetheless, it is still not universally applied by
pediatric or adult electrophysiologists.
Somewhat puzzling, is why it took so long to adapt a cryoablation
application strategy shown to be advantageous 40 years earlier. One
of the earliest publications systematically studying the use of
repeated freeze‐thaw cycles (for cancer treatment) can be found in
the 1968 Nature article by Gill et al,6 in which they demonstrate
clearly that repeated applications create larger lesions than single
applications. Likely, as knowledge of the pathobiology of cryoablation
grew along with a better understanding of the preclinical literature,
the technique changed to the current freeze‐thaw‐freeze method.
Larger lesions improve efficacy, but simultaneously have the
potential to increase the risk of collateral damage to adjacent
structures. Hence, the interest of Schneider et al1 to clarify the
potential for coronary artery damage. In clinical practice, it is easy to
see the immediate effects of cryoablation delivered too close to the
conduction system and terminate the application while the effect
remains reversible; however, it is not possible to be forewarned
about coronary artery damage during a cryoablation or RF ablation
before potentially serious complications occur.
There are many animal studies and numerous clinical reports
demonstrating the potential for coronary damage during RF ablation. In
fact, using a prospective imaging approach, Schneider and colleagues
found a 2% risk of producing coronary artery narrowing in pediatric
patients undergoing RF ablation for an accessory pathway.2 The clinical
incidence of coronary artery damage using RF ablation is mostly in case
reports; however, it has occurred often enough to lead to at least two
separate reviews.7,8 Alternatively, despite extensive use of cryoablation
in the posterior septum, literature evidence for cryoablation catheter
damage to the coronaries is essentially limited to that of Schneider and
colleaguesʼ laboratory work, and a single case report of transient
coronary spasm.9
How is it that tissue damage effects are quite different at the
coronary artery when comparing the two modalities? In addition to
the known shrinkage effects on elastic tissue with heating and RF,
which are not present with cooling and cryoablation, we
hypothesize that the protection of the coronary arteries also
results from a more rapid thawing phase of the cryoablation cycle.
The thawing phase of the freeze‐thaw cycle has an even more
prominent impact on tissue death than the freezing phase; slower
thawing is more damaging.10 Cryoablation lesions in high blood
flow areas are shown to be smaller than low flow areas.11 The
blood flow through the coronary likely acts as a continuous
rewarming circuit, thereby not allowing for full freeze at the
endothelium and rapid thawing once the lesion is complete,
attenuating effects at the vessel wall.12 Of course, it is likely that
these same coronary warming effects are also decreasing the
efficacy of cryoablation to eliminate APs at adjacent sites.
Primum non nocere—first, do no harm—the well‐known
mantra of the physician should come to mind when weighing
the evidence for cryoablation vs RF ablation. For the pediatric
patient especially, where adjacent structures are in closer
proximity and adverse consequences hold more serious life
implications, prioritization of safety over efficacy should be
standard. The Schneider study shows that even cryoablation can
have minor coronary effects, but quite minimal in comparison
with RF. Nonetheless, this added evidence for cryoablation safety
may still not sway the minds of those practitioners who have long
concluded that it is a less effective modality. Some feel that “in
their hands” RF ablation is definitely safe, perhaps even after
never evaluating the nearby coronaries. Of course, as stated
above, most RF‐related coronary injury is silent, and fortunately
even with RF, complete AV block is rare.
For those that favor cryoablation for selected substrates to limit
procedure risk, this study is just another satisfying reference in a
growing body of evidence. For now, the cryoablation vs RF ablation
battle will carry on. Unlike the popular television series, this will not
be the final season for the Game of Ablations!
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